Azelaic acid and Melaleuca alternifolia essential oil co-loaded vesicular carrier for combinational therapy of acne

Ther Deliv. 2022 Jan;13(1):13-29. doi: 10.4155/tde-2021-0059. Epub 2021 Nov 29.

Abstract

Aim: Azelaic acid (AzA), a comedolytic, antibacterial, anti-inflammatory anti-melanogenic agent, prescribed against acne vulgaris is safe on skin. Its combination with another widely used anti-acne agent, tea tree oil (EO) whose delivery is limited by volatility, instability and lipophilicity constraints was attempted. Method: Solvent injection was used to prepare AzA-EO integrated ethosomes. Result: Ethosomes were transformed into carbopol hydrogel, which exhibited pseudo-plastic properties with appreciable firmness, work of shear, stickiness and work of adhesion. The hydrogel showed better permeation and retention characteristics vis-a-vis commercial formulation (AzidermTM), when evaluated in Wistar rat skin. Further, ethosome hydrogel composite was better tolerated with no side effects. Conclusion: The findings suggests that the aforementioned strategy could be a potential treatment used for acne management.

Keywords: P. acne; agar well diffusion method; azelaic acid; broth microdilution assay; ethosomes; skin permeation.

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Animals
  • Anti-Bacterial Agents
  • Dicarboxylic Acids
  • Excipients
  • Hydrogels
  • Melaleuca*
  • Rats
  • Rats, Wistar
  • Tea Tree Oil* / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Dicarboxylic Acids
  • Excipients
  • Hydrogels
  • Tea Tree Oil
  • azelaic acid